Skip to content

Compensatory Reserve Index (CRI) for Management of COVID-19

CRI and Continuous Assessment of Hemodynamic Compensation to Guide Fluid and Pressor Management in Severely Ill Patients With COVID-19

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04457817
Enrollment
16
Registered
2020-07-07
Start date
2020-12-01
Completion date
2021-04-08
Last updated
2021-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID

Keywords

CRI, Compensatory Reserve Index, COVID-19, Coronavirus

Brief summary

The FDA has approved the CipherOx CRI T1 Tablet for use in subjects aged 19-36, and that this study aims to evaluate the device in subjects aged outside of this range and is being used off label. The FDA determined the Cipher OX CRI T1 Tablet to be a class II device in 2016, and additional research has been done since the FDA determination to further support the use of the device outside of its current labeling.

Interventions

DEVICECRI

Monitoring via CRI

Sponsors

Children's Hospital Colorado
CollaboratorOTHER
University of Colorado, Denver
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Eligible patients will be those who are: * COVID-19 positive; * Ages \> 18 and \< 70 years old; * Require \> 2 liters of oxygen by nasal cannula to maintain SpO2 \> 90%; * Are admitted to the sixth floor at University Hospital, on one of two designated Hospitalist services (approximately 16 COVID-19 positive patients/service).

Exclusion criteria

* COVID-19 negative * Age \<18 or \>70 years * On \<2 liters oxygen via nasal canula * Pregnant * Incarcerated * DNR/DNI * Decisionally Challenged

Design outcomes

Primary

MeasureTime frameDescription
Volume of IV fluid infused1 yearVolume of IV fluid infused during treatment
Quantity of Blood pressure medication administered1 yearAmount of blood pressure medication utilized during treatment
Resuscitation status1 yearCategorical determination of resuscitation status as over- or under- resuscitated
FiO2 needs1 yearFiO2 levels administered
Days on Oxygen1 yearDays spent on oxygen
Number of participants with hospital acquired pneumonia1 yearNumber of participants with hospital acquired pneumonia
Number of Patients with Acute Kidney Injury (AKI)1 yearNumber of patients who acquire an acute kidney injury
Number of patients with hemodynamic collapse1 yearNumber of patients who experience hemodynamic collapse defined as drop in systolic blood pressure below 80mm Hg
mortality1 yearNumber of patients who experience mortality

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026